These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 21719005

  • 1. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [Abstract] [Full Text] [Related]

  • 2. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [Abstract] [Full Text] [Related]

  • 3. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 4. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA, Groome NP, Baird DT.
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [Abstract] [Full Text] [Related]

  • 5. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA.
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [Abstract] [Full Text] [Related]

  • 6. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
    El-Mazny A, Abou-Salem N.
    Gynecol Endocrinol; 2013 Sep; 29(9):826-9. PubMed ID: 23855354
    [Abstract] [Full Text] [Related]

  • 7. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A, Abdelmeged A, El-Adawy AR, Eissa MK, Shaw RW, Amer SA.
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [Abstract] [Full Text] [Related]

  • 8. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P.
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [Abstract] [Full Text] [Related]

  • 9. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F, Liu XL, Rong N, Huang XW.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [Abstract] [Full Text] [Related]

  • 10. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Feb; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 11. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
    Hohmann FP, Laven JS, de Jong FH, Fauser BC.
    Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
    [Abstract] [Full Text] [Related]

  • 12. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM, Muttukrishna S, Groome NP, Matthews DR, Ledger WL.
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [Abstract] [Full Text] [Related]

  • 13. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, Dede A.
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [Abstract] [Full Text] [Related]

  • 14. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
    [Abstract] [Full Text] [Related]

  • 15. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 16. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 17. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
    Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkhäuser MH.
    Fertil Steril; 2008 Apr 01; 89(4):927-33. PubMed ID: 17603052
    [Abstract] [Full Text] [Related]

  • 18. Inhibin B levels on cycle day 3 to predict the ovulatory response in women with PCOS undergoing ovulation induction via low dose step-up gonadotropin protocol.
    Kökçü A, Turhan E, Cetinkaya MB, Yanik F, Alper T, Malatyalioğlu E.
    Arch Gynecol Obstet; 2004 Dec 01; 270(4):255-9. PubMed ID: 13680268
    [Abstract] [Full Text] [Related]

  • 19. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ.
    Fertil Steril; 2007 Apr 01; 87(4):870-5. PubMed ID: 17224152
    [Abstract] [Full Text] [Related]

  • 20. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1871-4. PubMed ID: 17299061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.